Evidence map›Paper›PMID 40526187›Full record

ArticleAnnals of nuclear medicine2025

Assessment of reduced

Xiaoyue Tan, Yongrong Zhou, Qing Zhang, Hui Yuan, Xinchao Yao, Chang Sun, Entao Liu, Lei Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoyue Tan *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Yongrong Zhou *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Qing Zhang *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Hui YuanPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Xinchao YaoPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Chang SunShanghai United Imaging Healthcare Advanced Technology Research Institute, Shanghai, China.
Entao LiuPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China. liuentao@gdph.org.cn.ORCID http://orcid.org/0000-0002-0388-5540
Lei JiangPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China. leijiang1031@163.com.ORCID http://orcid.org/0000-0002-9479-132X

Funding

Guangdong Provincial People's Hospital KY0120211130National Key R&D Program of China 2024YFF0509200National Natural Science Foundation of China 81971645
6 · The paper itself

Abstract

purposeThis study aimed to explore the feasibility of reduced

methodsForty-four pediatric patients (26 males, 18 females; median: 11 years [range, 1-17]) underwent

resultsSubjective image quality of 1/2 dose, 1/3 dose and 1/4 dose images was clinically acceptable (score ≥ 3), and all FDG-avid lesions could be identified in these three groups like full-dose group. SUVmax and standard deviation (SD) of blood pool and liver increased as the dose reduced, while no significant difference in SUVmean of blood pool and liver was found in 1/2-1/20 dose groups when compared to the full dose group. Besides, a significant difference was observed in SUVmax and SD of lesion and lesion-to-background ratio between 1/2-1/20 dose and full dose groups (p < 0.05).

conclusionFurther reduction in administered

Indexed as

Fluorodeoxyglucose F18Magnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyRadiation DosageAdolescentChildChild, PreschoolFemaleHumansImage Processing, Computer-AssistedInfantMaleRandom AllocationRetrospective StudiesFluorodeoxyglucose F1818F-FDGLow dosePediatricPET/MR

Identifiers

PMID40526187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.